Lv1
40 积分 2024-10-11 加入
Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
5天前
已关闭
How detection of immune-related adverse events fails during transfer of patients between medical sectors
5天前
已完结
Factors inducing cutaneous adverse reactions in cancer patients treated with PD-1 and PD-L1 inhibitors: a machine-learning algorithm approach
6天前
已完结
Evaluation and clinical impact of a pharmacist-led, interdisciplinary service focusing on education, monitoring and toxicity management of immune checkpoint inhibitors
6天前
已完结
Efficiency of Electronic Health Record Assessment of Patient-Reported Outcomes After Cancer Immunotherapy
7天前
已完结
Educating the cancer patient about the immunotherapy toxicity: a descriptive observational study
7天前
已关闭
Colitis Presenting 5 Months after the Final Dose of Anti-Pd-1: Long-Term Monitoring is Warranted after Adjuvant Therapy
7天前
已关闭
Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?
8天前
已完结
Symptom Clusters and Sentinel Symptoms in Patients With Colorectal Cancer: A Network Analysis
2个月前
已完结
Pre‐screening of patient‐reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer care
2个月前
已完结
皖公网安备34019202002308
